Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00530023 · ClinicalTrials.gov registry record · Phase 4
Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness
A Phase 4 study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- Phase 4
- Development phase
- 29
- Enrollment target
NCT00530023: Completed Phase 4 study, sponsored by Medtronic MiniMed.
NCT00530023 is a Phase 4 study that has completed, run by Medtronic MiniMed. The registered enrollment target is 29 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00530023, a Phase 4 study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 29 participants
- Enrollment target
Study Summary
Feasibility study to compare the effectiveness of the Paradigm Sensor Augmented System versus subjects continuing to administer insulin in multiple dose injections. Evaluate the educational materials and time required for training subjects naïve to continuous subcutaneous insulin infusion (CSII) to use the Paradigm 722 REAL Time System in preparation for a large multi-center clinical trial
Primary Outcome
Change in A1C measured from Baseline to week 15 will be compared. A1C measured as percent of glycated hemoglobin using a standardized assay for all subjects.
Interventions
- DEVICE MiniMed Paradigm REAL-Time System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2006-02 |
| Est. Completion | 2006-09 |
| Phase | Phase 4 |
What the finished NCT00530023 record still lists
NCT00530023 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which MiniMed Paradigm REAL-Time System is the first listed.
NCT00530023 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00530023 about?
NCT00530023 is a clinical study titled "Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness". Feasibility study to compare the effectiveness of the Paradigm Sensor Augmented System versus subjects continuing to administer insulin in multiple dose injections. Evaluate the educational materials and time required for training subjects naïve to continuous subcutaneous insulin infusion (CSII) to ...
What is the current status of trial NCT00530023?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 29 participants. The study started on 2006-02. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00530023?
The interventions under investigation include: MiniMed Paradigm REAL-Time System (DEVICE).
Who is sponsoring clinical trial NCT00530023?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00530023's enrollment target sits among peer trials
29 1634th of 2000 higher than 366 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia